the aid library

Filter

3116

Progress Toward Global Eradication of Dracunculiasis

Hopkins, D.; Weiss, A.; Roy, S. Morbidity and Mortality Weekly Report MMWR; National Libary of Medicine (2020) CC

Dracunculiasis (Guinea worm disease), caused by the parasite Dracunculus medinensis, is traditionally acquired by drinking water containing copepods (water fleas) infected with D. medinensis larvae, but in recent years also appears increasingly to be transmitted by eating fish or other aquatic anima ... more

Mpox Outbreak Toolbox, Updated: January 2023

World Health Organization WHO; Health Cluster (2024) CC

i. A person who is a contact of a probable or confirmed mpox case in the 21 days before the onset of signs or symptoms, and who presents with any of the following: acute onset of fever (>38.5°C), headache, myalgia (muscle pain/body aches), back ... more

Global atlas of palliative care at the end of life

World Palliative Care Alliance; WHO (2020) C_WHO

The second edition of the WHPCA Global Atlas of Palliative Care was launched during World Hospice & Palliative Care Day 10 October. The Atlas is an update of the original WHPCA/WHO Global Atlas of Palliative care at the end of life published in 2014. It is full of useful facts and figures to support ... more

Interim guidance on strengthening community detection and response during the mpox outbreak

World Health Organization WHO; Inernational Red Cross Federation IFRC (2025) C_WHO

Mpox, previously known as monkeypox, is a viral illness caused by the monkeypox virus (MPXV).1 It causes a painful rash, enlarged lymph nodes, fever, headache, muscle ache, back pain and low energy or feeling sick. In most cases, the symptoms of m ... more

Parasites - Guinea Worm

Center for Disease Control and Prevention CDC (2003) CC

People with Guinea worm disease (GWD) have no symptoms for about 1 year. Then, the person begins to feel ill. Symptoms can include the following: Slight fever Itchy rash Nausea Vomiting Diarrhea Dizziness A blister then develops. This blister can form anywhere on the skin. However, the blis ... more

Integrating palliative care and symptom relief into responses to humanitarian emergencies and crises: a WHO guide

World Health Organization WHO (2018) C_WHO

Humanitarian emergencies and crises (Humanitarian emergencies and crises) are large-scale events that may result in the breakdown of health care systems and society, forced displacement, death, and physical, psychological, social and spiritual suffering on a massive scale. Current responses to Human ... more

WHO: Ear care can avoid hearing loss (Video)

World Health Organization (WHO) (2014) C_WHO

What is good ear care? Should we clean our ears? How can noise affect our ears? Many myths and misconceptions are associated with ear problems and hearing loss. 360 million persons across the world have disabling hearing loss. About half of all these cases are easily prevented or treated. Following ... more

Rehabilitation Task Force Technical Note: Spinal Cord Injury Care in Gaza

Health Cluster; World Health Organization WHO (2024) C_WHO

The war in Gaza has resulted in many hundreds of spinal cord injuries (SCI), which will have a devastating impact on those injured and their families for the rest of their lives. The optimal management of SCI requires effective pre-hospital care, early specialized imaging (using CT or MRI) and in ... more

National Monkeypox Public Health Response Guidelines

Federal Ministry of Health - Nigeria Centre for Disease Control (2019) CC

Since the re-emergence of monkeypox in Nigeria in September 2017, the Nigeria Centre for Disease Control(NCDC) has continued to receive reports and respond to cases of the disease from States across the country. Between September 2017 when the outbreak started and November 2018, about 300 suspecte ... more

Occupational Lung Diseases - What are work-related lung diseases?

Cedars-Sinai Cedars-Sinai (2023) CC2

The Cedars-Sinai webpage on occupational lung diseases provides an overview of various lung conditions caused by exposure to harmful substances in the workplace. It outlines common types of occupational lung diseases, including asbestosis, silicosis, coal workers’ pneumoconiosis, and chemical-rela ... more

Breastfeeding Video Series

Global Health Media Project (2015)

These videos provide breastfeeding mothers with practical information on “how to” skills and problem management. Our goal is to help mothers become more successful with breastfeeding enabling more of them to exclusively breastfeed their babies until 6 months of age. The video topics are: Breas ... more

Palliative Care for Children

National Institute of Nursing Research (2015) C1

This brochure, available in English and Spanish, provides an overview of pediatric palliative care and answers questions that parents and families may have, such as: How do I know if my child or family needs palliative care? Does accepting palliative care mean our family is giving up on ot ... more

WHO guideline on balanced national controlled medicines policies to ensure medical access and safety

World Health Organization WHO (2025) C_WHO

Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those such as opioids, benzodiazepines, barbiturates, amphetamines and others with identified or emergent cl ... more

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for ... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

COLERA: INFORMAÇA O PARA PROMOTORES DE SAUDE ou ACTIVISTAS

World Health Organisation (WHO) (2019) C2

The PDF "COLERA: Informação para Promotores de Saúde" provides essential guidance for health promoters and activists on cholera. It explains that cholera is characterized by severe watery diarrhea, often resembling rice water, and sometimes vomiting. If not treated promptly, it can lead to death ... more

Standard treatment guidelines oncology India

Ministry of Health & Family Welfare, India (2020) C1

Accessed Febr. 6, 2020

Kenya national palliative care guidelines
recommended

Republic of Kenya, Ministry of Health (2013) C1

Linee guida dell’OMS sul trattamento farmacologico del dolore persistente nei bambini con patologie croniche gravi

World Health Organization Fondazione IRCCS, Istituto Nazionale dei Tumori (2014) C_WHO

EPIDEMIOLOGY OF MUSCULOSKELETAL DISORDERS IN PRIMARY SCHOOL CHILDREN IN BOSNIA AND HERZEGOVINA

Selma Azabagic, Razija Spahic, Nurka Pranjic, and Maida Mulic materia socio-medica (2016) CC

Musculoskeletal disorders represent a significant problem of modern society which are more pronounced in young people and school children. Etiology of these disorders is found in inadequate ergonomic conditions, too heavy school bag, school furniture inadequate to age, poor posture, sedentary lifest ... more

Standard treatment guidelines major trauma

Ministry of Health & Family Welfare, India (2014) C1